BCX.WA
Price:
$86.8
Market Cap:
$427.43M
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. Its products include BCX-CM-J, a stem-cell based biological drug for the treatment of degenerative joint lesions in dogs; BCX-CM-AD, a biological drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a biological drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was incorporated in 2018 and is based in Wroclaw, Poland.
Industry
Biotechnology
IPO Date
2021-11-08
Stock Exchange
WSE
Ticker
BCX.WA
According to Bioceltix S.A.’s latest financial reports and current stock price. The company's current ROE is -36.36%. This represents a change of 297.93% compared to the average of -9.14% of the last 4 quarters.
The mean historical ROE of Bioceltix S.A. over the last ten years is -88.55%. The current -36.36% ROE has changed -58.94% with respect to the historical average. Over the past ten years (40 quarters), BCX.WA's ROE was at its highest in in the December 2024 quarter at -7.85%. The ROE was at its lowest in in the March 2023 quarter at -104.46%.
Average
-88.55%
Median
-73.30%
Minimum
-173.20%
Maximum
-38.78%
Discovering the peaks and valleys of Bioceltix S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 136.30%
Maximum Annual ROE = -38.78%
Minimum Annual Increase = -70.35%
Minimum Annual ROE = -173.20%
| Year | ROE | Change |
|---|---|---|
| 2024 | -38.78% | -70.35% |
| 2023 | -130.77% | -24.50% |
| 2022 | -173.20% | 136.30% |
| 2021 | -73.30% | 3.69% |
| 2020 | -70.69% | -15.62% |
| 2019 | -83.78% | 69.80% |
The current ROE of Bioceltix S.A. (BCX.WA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-114.25%
5-year avg
-97.35%
10-year avg
-88.55%
Bioceltix S.A.’s ROE is greater than Bioton S.a. (-1.76%), greater than Ryvu Therapeutics S.A. (-89.88%), less than Centrum Medyczne ENEL-MED S.A. (8.97%), less than Scope Fluidics S.A. (50.53%), greater than Captor Therapeutics Spolka Akcyjna (-77.21%), less than Synthaverse S.A. (6.31%), greater than Medicalgorithmics S.A. (-20.71%), less than Mercator Medical S.A. (2.69%), greater than Mabion S.A. (-32.43%), greater than Poltreg S.A. (-37.19%),
| Company | ROE | Market cap |
|---|---|---|
| -1.76% | $343.46M | |
| -89.88% | $692.44M | |
| 8.97% | $497.73M | |
| 50.53% | $396.90M | |
| -77.21% | $383.67M | |
| 6.31% | $271.04M | |
| -20.71% | $344.37M | |
| 2.69% | $352.99M | |
| -32.43% | $130.11M | |
| -37.19% | $111.46M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bioceltix S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bioceltix S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Bioceltix S.A.'s ROE?
How is the ROE calculated for Bioceltix S.A. (BCX.WA)?
What is the highest ROE for Bioceltix S.A. (BCX.WA)?
What is the 3-year average ROE for Bioceltix S.A. (BCX.WA)?
What is the 5-year average ROE for Bioceltix S.A. (BCX.WA)?
How does the current ROE for Bioceltix S.A. (BCX.WA) compare to its historical average?